Guggenheim raised the firm’s price target on Sanofi to EUR 108 from EUR 102 and keeps a Buy rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SNY:
- Sanofi announces withdrawal, refiling of premerger notice on Provention Bio deal
- Sanofi to Spin Off India Consumer Unit
- IGM Biosciences Sanofi sees FY23 revenue $3M, consensus $5.5M
- Regeneron price target raised to $650 from $605 at BofA
- Sanofi price target raised to EUR 105 from EUR 100 at Berenberg